Kobayashi Pharmaceutical, headquartered in Japan, is a leading company that develops and distributes innovative pharmaceuticals, health products, and select consumer goods. The company is dedicated to research and development to offer products that improve the well-being and quality of life for consumers worldwide. Key focuses include OTC medications and everyday solutions for health and hygiene.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Kobayashi Pharmaceutical is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Kobayashi Pharmaceutical last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 1.34 JPY.
Across its last 4 earnings reports, Kobayashi Pharmaceutical stock moved by ±1.3% on average the following day. The largest reaction was +2% on 08/06/2026; 4 of 4 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.